Shawn H. MacVane

1.4k total citations
34 papers, 977 citations indexed

About

Shawn H. MacVane is a scholar working on Clinical Biochemistry, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Shawn H. MacVane has authored 34 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Biochemistry, 15 papers in Molecular Medicine and 15 papers in Applied Microbiology and Biotechnology. Recurrent topics in Shawn H. MacVane's work include Bacterial Identification and Susceptibility Testing (16 papers), Antibiotic Use and Resistance (15 papers) and Antibiotic Resistance in Bacteria (15 papers). Shawn H. MacVane is often cited by papers focused on Bacterial Identification and Susceptibility Testing (16 papers), Antibiotic Use and Resistance (15 papers) and Antibiotic Resistance in Bacteria (15 papers). Shawn H. MacVane collaborates with scholars based in United States. Shawn H. MacVane's co-authors include David P. Nicolau, Frederick S. Nolte, Joseph L. Kuti, Jared L. Crandon, Lisa L. Steed, Wright W. Nichols, Ruchi Pandey, Barry N. Kreiswirth, Liang Chen and Romney M. Humphries and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Shawn H. MacVane

34 papers receiving 959 citations

Peers

Shawn H. MacVane
Twisha S Patel United States
C Andrew DeRyke United States
Christina Sutherland United States
Christopher Lucasti United States
Elizabeth Neuner United States
Abdalhamid M Lagnf United States
William L. Musick United States
Twisha S Patel United States
Shawn H. MacVane
Citations per year, relative to Shawn H. MacVane Shawn H. MacVane (= 1×) peers Twisha S Patel

Countries citing papers authored by Shawn H. MacVane

Since Specialization
Citations

This map shows the geographic impact of Shawn H. MacVane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn H. MacVane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn H. MacVane more than expected).

Fields of papers citing papers by Shawn H. MacVane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn H. MacVane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn H. MacVane. The network helps show where Shawn H. MacVane may publish in the future.

Co-authorship network of co-authors of Shawn H. MacVane

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn H. MacVane. A scholar is included among the top collaborators of Shawn H. MacVane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn H. MacVane. Shawn H. MacVane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacVane, Shawn H., et al.. (2025). Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals. Clinical Infectious Diseases. 81(4). 710–720. 1 indexed citations
2.
Richter, Sandra S., et al.. (2025). Evaluation of MicroScan and VITEK 2 systems for susceptibility testing of Enterobacterales with updated breakpoints. Journal of Clinical Microbiology. 63(6). e0004825–e0004825. 2 indexed citations
3.
4.
Moon, Rena C., et al.. (2024). Clinical Outcomes of Early Phenotype-Desirable Antimicrobial Therapy for Enterobacterales Bacteremia. JAMA Network Open. 7(12). e2451633–e2451633. 1 indexed citations
5.
MacVane, Shawn H. & Hari P. Dwivedi. (2024). Evaluating the impact of rapid antimicrobial susceptibility testing for bloodstream infections: a review of actionability, antibiotic use and patient outcome metrics. Journal of Antimicrobial Chemotherapy. 79(Supplement_1). i13–i25. 11 indexed citations
6.
Al‐Hasan, Majdi N., Bruce M Jones, Kayla R. Stover, et al.. (2021). Novel method of calculating adjusted antibiotic use by microbiological burden. Infection Control and Hospital Epidemiology. 42(6). 688–693. 2 indexed citations
7.
MacVane, Shawn H., Amira A. Bhalodi, Ryan K Dare, et al.. (2021). Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit. Journal of Antimicrobial Chemotherapy. 76(9). 2453–2463. 8 indexed citations
9.
MacVane, Shawn H., et al.. (2019). Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture. European Journal of Clinical Microbiology & Infectious Diseases. 38(8). 1471–1479. 6 indexed citations
10.
MacVane, Shawn H., et al.. (2018). Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 51(4). 629–635. 27 indexed citations
11.
MacVane, Shawn H., et al.. (2018). Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation. Transplant Infectious Disease. 20(3). e12878–e12878. 9 indexed citations
12.
Bosso, John A., et al.. (2017). Intravenous‐only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae‐Associated Bacteremic Urinary Tract Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(11). 1479–1483. 36 indexed citations
13.
Fisher, Jonathan R. B., et al.. (2017). 666: INCIDENCE AND RISK FACTORS FOR LINEZOLID-ASSOCIATED THROMBOCYTOPENIA IN CRITICALLY ILL PATIENTS. Critical Care Medicine. 46(1). 319–319. 1 indexed citations
14.
MacVane, Shawn H.. (2016). Antimicrobial Resistance in the Intensive Care Unit. Journal of Intensive Care Medicine. 32(1). 25–37. 141 indexed citations
16.
MacVane, Shawn H., et al.. (2016). Voriconazole concentration monitoring at an academic medical center. American Journal of Health-System Pharmacy. 73(5_Supplement_1). S14–S21. 12 indexed citations
17.
MacVane, Shawn H., et al.. (2014). Demography and burden of care associated with patients readmitted for urinary tract infection. Journal of Microbiology Immunology and Infection. 48(5). 517–524. 15 indexed citations
18.
Nicolau, David P., Shawn H. MacVane, & Seth T. Housman. (2014). In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone. Clinical Pharmacology Advances and Applications. 6. 97–97. 10 indexed citations
19.
MacVane, Shawn H., et al.. (2014). Impact of extended‐spectrum β‐lactamase–producing organisms on clinical and economic outcomes in patients with urinary tract infection. Journal of Hospital Medicine. 9(4). 232–238. 115 indexed citations
20.
MacVane, Shawn H., Joseph L. Kuti, & David P. Nicolau. (2013). Prolonging β-lactam infusion: A review of the rationale and evidence, and guidance for implementation. International Journal of Antimicrobial Agents. 43(2). 105–113. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026